<DOC>
	<DOC>NCT00581035</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and immunogenicity of concomitant Prevenar and Meningitec compared to Prevenar alone and Meningitec alone when used as part of the routine vaccination series in healthy infants</brief_summary>
	<brief_title>Study Evaluating the Safety and Ability to Produce Immune Response of Prevenar and Meningitec Given at the Same Time</brief_title>
	<detailed_description />
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Healthy infants aged 6 to 9 weeks</criteria>
	<gender>All</gender>
	<minimum_age>42 Days</minimum_age>
	<maximum_age>63 Days</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Meningococcal disease</keyword>
	<keyword>pneumococcal disease</keyword>
	<keyword>meningitis</keyword>
</DOC>